Skip to content

Clinical effect of pharmacist and physician co-led multidisciplinary-collaborated cancer support team for gastrointestinal cancer chemotherapy

Clinical effect of pharmacist and physician co-led multidisciplinary-collaborated cancer support team for gastrointestinal cancer chemotherapy - MCST renovates cancer supportive treatment: M-CAST study

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-jRCT1030220495
Enrollment
120
Registered
2022-12-08
Start date
2022-12-08
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gastrointestinal cancer Gastrointestinal cancer

Interventions

None listed

Sponsors

Yohei Iimura
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: (i) Withdrawal of consent (ii) Patients undergoing cancer chemotherapy at our hospital (iii) Patients with MCST intervention (iv) age >18 years old.

Exclusion criteria

Exclusion criteria: none

Design outcomes

Primary

MeasureTime frame
Number of co-medical interventions Number of improvement of side effects by co-medical intervention and their degree

Secondary

MeasureTime frame
Severity of side effects before and after co-medical intervention Medical expenses for one course of anticancer drug treatment before and after co-medical intervention Number of consultations between different professions Acceptance rate of prescription recommendations to physician by co-medicals Adjuvant chemotherapy completion rates, dose intensity Patient interview time required for co-medicals intervention.

Contacts

Public ContactYohei Iimura

The IMSUT Hospital, The Institute of Medical Science, The University of Tokyo

iyouhei-tky@umin.ac.jp+81-3-3443-8111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026